BioSyent Inc. (TSXV:RX)
Canada
· Delayed Price · Currency is CAD 10.95
+0.15 (1.39%)
May 2, 2025, 3:43 PM EDT
BioSyent Revenue
In the year 2024, BioSyent had annual revenue of 35.03M CAD with 10.89% growth. BioSyent had revenue of 8.80M in the quarter ending December 31, 2024, with 6.32% growth.
Revenue
35.03M
Revenue Growth
+10.89%
P/S Ratio
3.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
123.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.03M | 3.44M | 10.89% |
| Dec 31, 2023 | 31.59M | 3.67M | 13.12% |
| Dec 31, 2022 | 27.93M | -693.03K | -2.42% |
| Dec 31, 2021 | 28.62M | 6.29M | 28.15% |
| Dec 31, 2020 | 22.33M | 907.84K | 4.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.71B |
| Extendicare | 1.47B |
| Curaleaf Holdings | 1.93B |
| WELL Health Technologies | 919.69M |
| Cronos Group | 169.23M |
BioSyent News
- 3 days ago - BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 18 days ago - BioSyent to Attend Planet MicroCap Showcase - GlobeNewsWire
- 4 weeks ago - BioSyent to Present at LD Micro New York Investor Conference - Newsfile Corp
- 6 weeks ago - BioSyent Announces Grant of Restricted Share Units - GlobeNewsWire
- 7 weeks ago - BioSyent Inc. (BIOYF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - BioSyent reports Q4 results - Seeking Alpha
- 7 weeks ago - BioSyent Releases Financial Results for Fourth Quarter and Full Year 2024 - GlobeNewsWire
- 2 months ago - BioSyent Schedules Fourth Quarter and Full Year 2024 Earnings Release for March 13, 2025 - GlobeNewsWire